These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38501328)

  • 1. Implantable cardioverter-defibrillator lead failure and revision following transcutaneous bicaval valve (TricValve®) implantation.
    Plant A; Stewart F; Hooks D
    J Cardiovasc Electrophysiol; 2024 May; 35(5):1050-1054. PubMed ID: 38501328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry.
    Taramasso M; Gavazzoni M; Pozzoli A; Alessandrini H; Latib A; Attinger-Toller A; Biasco L; Braun D; Brochet E; Connelly KA; de Bruijn S; Denti P; Deuschl F; Estevez-Louriero R; Fam N; Frerker C; Ho E; Juliard JM; Kaple R; Kodali S; Kreidel F; Kuck KH; Lauten A; Lurz J; Monivas V; Mehr M; Nazif T; Nickening G; Pedrazzini G; Praz F; Puri R; Rodés-Cabau J; Schäfer U; Schofer J; Sievert H; Tang GHL; Khattab AA; Thiele H; Unterhuber M; Vahanian A; Von Bardeleben RS; Webb JG; Weber M; Windecker S; Winkel M; Zuber M; Hausleiter J; Lurz P; Maisano F; Leon MB; Hahn RT
    JACC Cardiovasc Interv; 2020 Mar; 13(5):554-564. PubMed ID: 31954676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
    Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD
    Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventional Treatment of Severe Tricuspid Regurgitation: Early Clinical Experience in a Multicenter, Observational, First-in-Man Study.
    Lauten A; Figulla HR; Unbehaun A; Fam N; Schofer J; Doenst T; Hausleiter J; Franz M; Jung C; Dreger H; Leistner D; Alushi B; Stundl A; Landmesser U; Falk V; Stangl K; Laule M
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e006061. PubMed ID: 29445001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bicaval TricValve Implantation in Patients With Severe Symptomatic Tricuspid Regurgitation: 1-Year Follow-Up Outcomes.
    Blasco-Turrión S; Briedis K; Estévez-Loureiro R; Sánchez-Recalde A; Cruz-González I; Pascual I; Mascherbauer J; Abdul-Jawad Altisent O; Nombela-Franco L; Pan M; Trillo R; Moreno R; Delle Karth G; Sánchez-Luna JP; Gonzalez-Gutiérrez JC; Revilla-Orodoea A; Zamorano JL; Gómez-Salvador I; Puri R; San Román JA; Amat-Santos IJ
    JACC Cardiovasc Interv; 2024 Jan; 17(1):60-72. PubMed ID: 38069986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricuspid Valve Dysfunction Following Pacemaker or Cardioverter-Defibrillator Implantation.
    Chang JD; Manning WJ; Ebrille E; Zimetbaum PJ
    J Am Coll Cardiol; 2017 May; 69(18):2331-2341. PubMed ID: 28473139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative technique for implanting an epicardial cardioverter defibrillation patch during a tricuspid valve replacement for arrhythmogenic right ventricular cardiomyopathy.
    Yoda M; Tanabe H; Kishi M; Suma H
    Interact Cardiovasc Thorac Surg; 2011 Apr; 12(4):628-30. PubMed ID: 21220415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Transcatheter Edge-to-Edge Repair of the Tricuspid Valve in Patients With Cardiac Implantable Electronic Device Leads.
    Lurz J; Rommel KP; Unterhuber M; Besler C; Noack T; Borger M; Richter S; Hindricks G; Thiele H; Lurz P
    JACC Cardiovasc Interv; 2019 Oct; 12(20):2114-2116. PubMed ID: 31648771
    [No Abstract]   [Full Text] [Related]  

  • 9. Implantable cardioverter-defibrillator lead revision following left ventricular assist device implantation.
    Black-Maier E; Lewis RK; Rehorn M; Loungani R; Friedman DJ; Frazier-Mills C; Jackson KP; Atwater BD; Milano CA; Schroder JN; Pokorney SD; Piccini JP
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1509-1518. PubMed ID: 32275340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve.
    Figulla HR; Kiss K; Lauten A
    EuroIntervention; 2016 Sep; 12(Y):Y116-8. PubMed ID: 27640022
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation.
    Addetia K; Harb SC; Hahn RT; Kapadia S; Lang RM
    JACC Cardiovasc Imaging; 2019 Apr; 12(4):622-636. PubMed ID: 30947905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First In-Man Experience With TricValve Transcatheter Bicaval Valve System in Left Ventricular Assist Device Heartmate II Patient for High-Risk Tricuspid Regurgitation.
    Chandran K; Long A; Bishop J; Berman P; Matar F; Oliveira GH; Bezerra HG
    Circ Heart Fail; 2023 Jun; 16(6):e010027. PubMed ID: 37278243
    [No Abstract]   [Full Text] [Related]  

  • 13. Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure.
    Nichols CI; Vose JG; Mittal S
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead dependent tricuspid dysfunction: Analysis of the mechanism and management in patients referred for transvenous lead extraction.
    Polewczyk A; Kutarski A; Tomaszewski A; Brzozowski W; Czajkowski M; Polewczyk M; Janion M
    Cardiol J; 2013; 20(4):402-10. PubMed ID: 23913459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex Tricuspid Valve Repair in Patients With Pacer Defibrillator-Related Tricuspid Regurgitation.
    Raman J; Sugeng L; Lai DT; Jeevanandam V
    Ann Thorac Surg; 2016 Apr; 101(4):1599-601. PubMed ID: 27000589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate, causes, and impact on patient outcome of implantable device complications requiring surgical revision: large population survey from two centres in Italy.
    Palmisano P; Accogli M; Zaccaria M; Luzzi G; Nacci F; Anaclerio M; Favale S
    Europace; 2013 Apr; 15(4):531-40. PubMed ID: 23407627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart Transplantation in a Patient With a Heterotopic Percutaneous Tricuspid Valve Prosthesis: A Case Report.
    Adsuar-Gómez A; Rodríguez-Mora F; González-Calle A; Ramos-Barragán B; Rezaei K; Sobrino-Márquez JM; Rangel-Sousa D; Borrego-Domínguez JM
    Transplant Proc; 2023 Dec; 55(10):2312-2314. PubMed ID: 37925232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P; Özer N; Ateş AH; Yorgun H; Oto A; Aytemir K
    Cardiol J; 2015; 22(6):637-44. PubMed ID: 26412607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iatrogenic Palpitations during Exercise in a Patient with a Dual Chamber Implantable Cardioverter-Defibrillator and Lead Dysfunction.
    Hasegawa K; Miyazaki S; Kaseno K; Tada H
    Int Heart J; 2019 Mar; 60(2):462-465. PubMed ID: 30626767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implantable cardioverter-defibrillator lead failure: how weak is the link?
    Brinker JA
    Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):758-9. PubMed ID: 18838965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.